Resumen
Objetivos: Evaluar las principales alteraciones en la cognición y el sueño en pacientes con síndrome post-COVID-19. Métodos: Estudio analítico transversal. Se evaluaron 51 pacientes mayores de 18 años con síndrome post-COVID-19 que presentaban quejas cognitivas y de sueño, a través de un formulario propio y cuestionarios validados para cognición (MoCA y MoCA-B) y para el sueño (Escala de Somnolencia de Epworth, Índice de Calidad del Sueño de Pittsburgh, Cuestionario de Perturbación del Sueño e Índice de Gravedad del Insomnio). Resultados: La muestra estuvo predominantemente compuesta por mujeres (80,4%), con una edad promedio de 59,9 años y gravedad leve de COVID-19 (52,9%). Las quejas neurocognitivas (90,2%) y del sueño (96,1%) fueron prevalentes, ocurriendo independientemente de la gravedad de la enfermedad. En la cognición predominaban las alteraciones en la memoria a corto plazo y, en el sueño, la somnolencia y la fatiga. En las pruebas MoCA y MoCA-B, el 81,57% presentó deterioro cognitivo leve. Las pruebas del sueño mostraron impactos en la calidad y cantidad del sueño, sin una correlación significativa entre las pruebas de trastornos del sueño y las evaluaciones cognitivas agrupadas. Conclusión: Los impactos en la cognición y el sueño en el síndrome post-COVID-19 deben ser el foco de atención de los equipos de salud que intervienen en esta población, ya que son prevalentes y pueden ocasionar perjuicios biopsicosociales.
Referencias
AHMED GK, et al. Long term impact of Covid-19 infection on sleep and mental health: A cross-sectional study. Psychiatry research, 2021; 305: 114243.
ANAYA JM, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmunity reviews, 2021; 20(11): 102947.
BERTUCCELLI M, et al. Cognitive impairment in people with previous COVID-19 infection: A scoping review. Cortex; a journal devoted to the study of the nervous system and behavior, 2022; 154: 212-230.
CIPOLLI GC, et al. Cognitive impairment in post-acute COVID-19 syndrome: a scoping review. Arquivos de neuropsiquiatria, 2023; 81(12): 1053-1069.
CRIVELLI L, et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimer's & dementia: the journal of the Alzheimer's Association, 2022; 18(5): 1047-1066.
DAMIANO RF, et al. Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. European archives of psychiatry and clinical neuroscience, 2023; 273(2): 325-333.
GOMES LPOZ, et al. Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature. Arquivos de neuropsiquiatria, 2024; 82(1): 1-8.
IDA FS, et al. Post-COVID-19 syndrome: persistent symptoms, functional impact, quality of life, return to work, and indirect costs - a prospective case study 12 months after COVID-19 infection. Cadernos de saude publica, 2024; 40(2): e00022623.
JAHRAMI H, et al. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine, 2021; 17(2): 299-313.
JAROSCH I, et al. Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial. Respiration; international review of thoracic diseases, 2024, 103(4): 177-181.
MARTIN EM, et al. Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months. Journal of neurology, 2024; 271(1): 46-58.
MILL JG, POLESE J. Post-COVID Syndrome or Long COVID: A New Challenge for the Healthcare System. Síndrome Pós-COVID ou COVID Longa: Um Novo Desafio para o Sistema de Saúde. Arquivos brasileiros de cardiologia, 2023; 120(11): e20230750.
MONJE M, IWASAKI A. The neurobiology of long COVID. Neuron, 2022; 110(21): 3484-3496.
NALBANDIAN A, et al. Post-acute COVID-19 syndrome. Nature medicine, 2021; 27(4): 601-615.
NICOTRA A, et al. What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection. European journal of neurology, 2023; 30(12): 3968-3978.
ONYEAKA H, et al. COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Science progress, 2021; 104(2): 368504211019854.
PAI N, VELLA SL. The physical and mental health consequences of social isolation and loneliness in the context of COVID-19. Current opinion in psychiatry, 2022; 35(5): 305-310.
PELLITTERI G, et al. Sleep alterations following COVID-19 are associated with both neuroinflammation and psychological disorders, although at different times. Frontiers in neurology, 2022; 13: 929480.
PERCZE AR, et al. Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms. Inflammopharmacology, 2023; 1-7.
PREMRAJ L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Journal of the neurological sciences, 2022; 434: 120162.
RAVEENDRAN AV, et al. Long COVID: An overview. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15(3): 869-875.
SCHILLING C, et al. Kognitive Störungen und Schlafstörungen bei Long-COVID. Der Nervenarzt, 2022; 93(8): 779-787.
STEFANO GB, et al. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival. Medical science monitor: international medical journal of experimental and clinical research, 2021; 27: e930886.
STEFANO GB. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID. Medical science monitor: international medical journal of experimental and clinical research, 2021; 27: e931447.
WOO MS, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain communications, 2020; 2(2): fcaa205.
XIONG J, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of affective disorders, 2020; 277: 55-64.
XU E, et al. Long-term neurologic outcomes of COVID-19. Nature medicine, 2022; 28(11): 2406-2415.
ZIFKO U, et al. Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care. Frontiers in pharmacology, 2024; 15: 1338235.
ZÜLKE AE, et al. Cognitive performance in adults with post-COVID syndrome: Results from a German case-control study. Journal of Psychiatric Research, 2024; 176: 377-383.
